Factors Affecting the Compliance to Treatment with Anticonvulsants in Epilepsy (Review of Literature)
УДК 616-08-07
Vagina M.A., Volkova L.I.
GBUS SO «Sverdlovsk Regional Clinical Hospital 1», Yekaterinburg, Russian Federation;
GBOU VPO «Ural state medical university of Ministry of Health of Russia», Yekaterinburg, Russian Federation
Abstract. Commitment violation to therapy by anti-epileptic preparations (AEP) is observed from 30 to 40% suffering epilepsy that causes disease failures. Non-compliance with a mode of treatment leads to increase in frequency of epileptic attacks that involves increase in direct and indirect costs of health care. Not commitment to treatment by AEP increases incidence and mortality. Now it is identified about 250 factors causing the relation of patients to observance of a mode of therapy. 4 main groups are allocated: the factors connected with therapy (reception frequency, quantity of preparations, side effects); the factors connected with the patient, with his personality (education, the relation to an illness, etc.) and a disease (features of attacks and a current, etc.); the factors connected with interaction “doctor — patient”, professionalism of the doctor and socio-economic factors (an environment of the patient, professional activity, level of availability of the specialized help and medicines). Further studying of the reasons of low commitment to therapy, including in the Russian population of patients, will allow to improve system of rendering specialized medical care by the patient with epilepsy.
Key words: epilepsy, komplayentnost, therapy.
REFERENCES
1. Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics. 2002;20(15):1039-59
2. Leppik I.E. Сompliance during treatment of epilepsy. Epilepsia; 1988; V.29 (suppl2); P.79–84.
3. Jin J., Sklar G. E., Oh M.N.S, Li S.C. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther. Clin. Risk Manag.; 2008; V. 4(1); P. 269–286
4. Manjunath R., Davis K.L., Candrilli S.D., Ettinger A.B. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav. — 2009. — Vol. 14, N 2. — P. 372—378.
5. Faught E., Duh M.S., Weiner J.R. et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology, 2008; V. 71(20); P. 1572–8.
6. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991;48:1978–88.
7. Semenova O. N., Naumova E.A. The factors influencing commitment to therapy: parameters of WHO and opinion of patients of cardiological office//Bulletin medical Internet (ISSN2224-6150)2013 conferences. T/3, No. 3-C.507-511.
8. Okuno J, Yanagi H, Tomura S. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol 2001;57:589–94.
9. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging 1998;12:7–15.
10. Kyngas H. Predictors of good compliance in adolescents with epilepsy. Seizure; 2001; V. 10 (8); P. 549–53.
11. Pitmman P. Gendered experiences of healf care // Intern. J. for Quality in Health Care. — 1999; 11: 397-405.
12. Patients' problems with new medication for chronic condition / N. Barber, J. Parson, S. Clifford et al. // Am. J. Health. Syst. Pharm. 2004; 61(14): 1473 — 1478.
13. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509–10.
14. Simpson, S.H. A meta-analysis of the association between adherence to drug therapy and mortality / S.H.Simpson, D.T.Eurich, S.R.Majumdar // BMJ. 2006. №333. Р.15.
15. Britten N. Patients' ideas about medicines: a qualitative study in a general practice population // Br. J. Gen. Pract.- 1994; 44(387): 465-468.
16 Bartlett EE, Grayson M, Barker R, et al. The effects of physician communications skills on patient satisfaction; recall, and adherence J Chronic Dis 1984;37:755–64.
17. Hope CJ, Wu J, Tu W, et al. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004;61:2043–9.
18. Ettinger A.B., Manjunath R., Candrilli S.D., Davis K.L. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav; 2008.
19. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990;150:1377–8.
20. Gonzalez J,Williams JW Jr,Noel PH,et al. Adherence to mental health treatment in a primary care clinicJ Am Board Fam Pract 2005;18:87–96.
21. Opolka JL,Rascati KL,Brown CM,et al. Role of ethnicity in predicting antipsychotic medication adherence. Ann Pharmacother 2003;37:625–30.
22. Mitchell W.G., Scheier L.M., Baker S.A. Adherence to treatment in children with epilepsy: who follows «doctor’s orders» Epilepsia; 2000; V. 41(12); P. 1616–25.
23. Christensen DB. Drug-taking compliance: a review and synthesis. Health Serv Res 1978;13:171–87.
24. Department of Health. The expert patient: a new approach to chronic disease management for the 21st century / London: DoH, 2001. 120 p.
25. Buck D., Jacoby A., Baker G.A., Chadwick D.W. Factors influencing compliance with antiepileptic drug regimes. Seizure; 1997; V.6; P.87–93.
26. Cramer JA, Mattson RH,Prevey ML,et al. How often is medication taken as prescribed? A novel assessment techniqueJAMA 1989;261:3273–7.
27. Pellock J.M., Smith M.C., Cloyd e J. C. t al. Extended–release formulations: simplifying strategies in the management of antiepileptic drug therapy Epilepsy Behavior; 2004; V.5; P. 301–307.
28. Modi A.C., Morita D.A., Glauser T.A. One–month adherence in children with new–onset epilepsy: white–coat compliance does not occur. Pediatrics; 2008; V. 121(4); P. 961–6.
29. Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence. Pediatr Transplant 2005;9:357–63.
30. Trostle J. Doctors’ orders and patients’ self–interest: Two views of medication usage (chap 4) In: Schmidt D, Leppik IE, eds. Compliance in Epilepsy. New York, NY: Elsevier Science Publishers BV (Biomedical Division); 1988; P. 57–69.
31. Belousova E.D. Problema of a komplayentnost at the patients having epilepsy//the Russian Medical Magazine — 2009. — No. 5 — Page 380-383.
32. Gecht A.B. Modern standards of maintaining patients with epilepsy and basic principles of treatment//Consilium medicum. — 2000. — T. 2, No. 2. — Page 2-11.
Authors
Vagina Marina A. marina19772008@yandex.ru
GBUS SO «Sverdlovsk Regional Clinical Hospital 1»
The neurologist of specialized reception of patients with epilepsy
185, Volgogradsaya st., Yekaterinburg, Russian Federation, 620102
Volkova Larisa I. vli@okb1.ru
GBOU VPO «Ural State Medical University of Ministry of Health of Russia»
Head of the Department of nervous diseases and neurosurgery, MD.
3, Repina st., Yekaterinburg, Russian Federation